This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Is It Worth Investing in Modine (MOD) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Modine (MOD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MODPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Chewy (CHWY) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Chewy (CHWY) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CHWYNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
ACM Research (ACMR) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for ACM Research (ACMR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ACMRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Intuit (INTU) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Intuit (INTU) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
INTUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Cipher Mining (CIFR) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Cipher Mining (CIFR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CIFRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Kroger (KR): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Kroger (KR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
KRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About AppFolio (APPF): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in AppFolio (APPF). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
APPFPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See AudioEye (AEYE) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), AudioEye (AEYE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AEYENegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Adobe (ADBE) Based on Bullish Wall Street Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Adobe (ADBE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ADBEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Ares Capital (ARCC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Ares Capital (ARCC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ARCCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in MicroStrategy (MSTR): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for MicroStrategy (MSTR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MSTRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Humacyte, Inc. (HUMA) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Humacyte, Inc. (HUMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HUMAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Levi Strauss (LEVI): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Levi Strauss (LEVI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
LEVIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VKTXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Crocs (CROX): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Crocs (CROX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CROXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About MakeMyTrip (MMYT): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for MakeMyTrip (MMYT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MMYTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in United (UAL): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for United (UAL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
UALPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Cava (CAVA) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Cava (CAVA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CAVANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Carvana (CVNA) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Carvana (CVNA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CVNAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Sunoco LP (SUN): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Sunoco LP (SUN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SUNNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Owens Corning (OC): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Owens Corning (OC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
OCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Twilio (TWLO) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Twilio (TWLO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
TWLOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Look Bullish on Abercrombie (ANF): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Abercrombie (ANF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ANFPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is ARKO (ARKO) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), ARKO (ARKO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ARKOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is AppLovin (APP) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in AppLovin (APP). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
APPNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth